Skip to main content
العنوان الوكيل الحالة الدواء المرحلة رقم البروتوكول موقع الدراسة
Use of high dose of Colistin in Multidrug Resistant Gram Negative infections. Randomized Controlled clinical Trial
King Saud Medical City
Completed Colistin
4 KSMC-12-13
King Saud Medical City
"easypod connect: A regional, Multicentre, Observational study to evaluate Adherence
and Long Term Outcomes of Therapy in Paediatric subjects using “easypodTM” electromechanical device for growth hormone treatment"
Merck Serono
Rejected 4 200104-534
King Khalid University Hospital (Riyadh)
"AN OBSERVATIONAL, NON-INTERVENTIONAL,
MULTI-CENTER, MULTI-NATIONAL STUDY OF
PATIENTS WITH ATYPICAL HEMOLYTIC-UREMIC
SYNDROME
(AHUS REGISTRY)"
Alexion
Rejected 4 M11-001
N/A
A Phase IV Double-Blind Placebo-Controlled Randomized Clinical Trial Assessing the Effect of 2 month consumption of Vetal Laban Including Lactobacillus acidophilus NCFM on Functional Gastrointestinal Symptoms Among Subjects Fulfilling Rome III Criteria for A Phase IV, Randomized, double-blind, placebo-controlled study with parallel groups Irritable Bowel Syndrome
Almarai
Rejected Vetal Laban containing Lactobacillus acidophilus NCFM at 1.6 x 109 CFU per container
4 IBS - 0920
King Fahad Medical City (Riyadh)
"An Open-label, Multicentre, Randomised, 2-arm Study to Investigate the Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose Versus Oral Iron for the Treatment of Iron Deficiency Anaemia in Pregnant Women"
Vifor Pharma

Terminated Ferrous Sulphate + Ferinject
3 FER-ASAP-2009-01
King Faisal Specialist Hospital and Research Center (Riyadh)
The Effectiveness of Convalescent Plasma for the Treatment of Severe COVID-19 Cases in Intensive Care Unit
King Faisal Specialist Hospital and Research Centre
Ongoing Convalescent Plasma
3 IRB 2020-19-V2
King Faisal Specialist Hospital and Research Center (Jeddah)
An Open Label, Phase IV, Multi-Centric, Prospective, Single Arm Study to Assess the Safety and Efficacy of Dexaflox Eye Drops Containing Ofloxacin (3 mg) and dexamethasone (1 mg) in Subjects with Bacterial Conjunctivitis
Jamjoom Pharmaceuticals
Completed Dexaflox
4 DEXA001
King Khalid University Hospital (Riyadh)
An Open Label, Phase IV, Multi-Centric, Prospective, Single Arm Study to Assess the Safety and Efficacy of Loxtra Eye Drops Containing Ofloxacin (3 mg), Prednisolone (2 mg) and Tetrahydrozoline Hydrochloride (0.4 mg) in Subjects with Bacterial Conjunctivitis and Other Ocular Inflammatory Conditions
Jamjoom Pharmaceuticals
Completed Loxtra
4 LOX001
King Khalid University Hospital (Riyadh)
An Open Label, Phase IV, Multi-Centric, Prospective, Single Arm Study to Assess the Safety and Efficacy of Fluca Eye Drops Containing Sodium Cromoglycate (20 mg/ml) and Fluorometholone (1 mg/ml) in Subjects with Chronic Allergic Conjunctivitis and Hay Fever
Jamjoom Pharmaceuticals
Completed FLUCA
4 FLUCA001
King Khalid University Hospital (Riyadh)
An open label, Phase IV Multicentric Single Arm Study to Assess the Safety and Efficacy of Croma Ophthalmic Solution Containing Sodium Cromoglycate (40 mg/ml) and Tetrahydrozoline Hydrochloride (0.5 mg/ml) in Subjects with Chronic Allergic Conjunctivitis and Hay Fever (Seasonal)
Jamjoom Pharmaceuticals
Completed Croma
4 CROMA001
King Khalid University Hospital (Riyadh)
عرض 1 - 10 من 353